New therapeutic opportunities: from AIFA ok to the reimbursement of 16 drugs
The board of directors of the Italian Medicines Agency (AIFA), in its November meeting, approved the admission to reimbursement by the National Health Service (SSN) of 16 drugs, including 14 active ingredients. The Agency itself made this known on 27 November 2024. The authorization granted by AIFA concerns, in the context of orphan drugs, two … Read more